The optimal duration of oral anticoagulant therapy following proximal deep vein thrombosis
(DVT) in the lower limbs remains controversial. To compare the risk benefit tradeoffs for …

Background Clinical processes that span the boundary between primary and secondary
care often suffer from poor standardization of practice and lines of communication. One …

Recent data from randomized trials have provided a clear understanding of the effectiveness
and safety of differing long-term anticoagulant therapies for proximal vein thrombosis. An …

Background: Effective heparin therapy, defined by therapeutic prolongation of the activated
partial thromboplastin time (APTT), decreases the risk of recurrentvenous thromboembolism …

Entry into clinical trials of treatment for deep venous thrombosis (DVT) involves a screening
process that excludes many patients with this condition. Therefore, to obtain a profile of …

Background Despite NICE guidelines, the early management of deep vein thrombosis (DVT)
in UK hospitals varies widely. We investigated the variation in clinical pathways used in NHS …

Study objectives To develop and to evaluate selection criteria for outpatient management of
deep venous thrombosis (DVT). Design We developed outpatient treatment eligibility criteria …

There have been a large number of randomized trials comparing standard unfractionated
intravenous heparin with low–molecular-weight heparin for the treatment of deep-vein …

MONTES, J. et al. Tratamiento domiciliario de la trombosis venosa profunda: Comparación
de costes con la hospitalización convencional. An. Med. Interna (Madrid)[online]. 2005, vol …